Table 2 HPV incidence in women without cervical abnormalities
Author | Area, subjects | Study design | HPV test | HPV incidence rate for any, HR*, LR** and type-specific genotypes among all tested womena per 100 PYs | HPV incidence for any and type-specific genotypes all tested womena per 100 PYs by HIV status | Comments |
|---|---|---|---|---|---|---|
Safaeian et al., 2008a [24] | Rakai district, rural women, median age 29 years (range, 15-59 years) | Prospective cohort | HC 2/PGMY/09/11 assay | Any HR-HPVa, 8.7 Type-specific genotypes a HPV 16, 1.5 HPV 18, 0.9 HPV 45, 1.1 HPV 51, 1.8 HPV 52, 1.1 | HIV Positive Any HR-HPVa, 17.3 Type-specific genotypes a HPV 16, 3.2 HPV 18, 2.1 HPV 45, 2.7 HPV 51, 5.1 HPV 52, 1.3 HIV Negative Any HR-HPVa , 7.0 Type-specific genotypes a HPV 16, 1.2 HPV 18, 0.7 HPV 45, 0.8 HPV 51, 1.2 HPV 52, 1.0 | HIV prevalencea, 14.0% |
Banura et al., 2010 [25] | Teenage clinic in Kampala, 380 young women, median age at baseline 19 years (range, 12-24) | Prospective cohort | SPF10/LIPA PCR assay | Any HPVa, 30.5 HR-HPV types, 20.9 LR-HPV types, 10.6 HPV 16-related types, 10.8 HPV 18-related types, 5.6 Type-specific genotypes HR-HPV genotypes a HPV 16, 3.3 HPV 18, 2.0 HPV 45, 1.3 HPV 51, 4.2 HPV 52, 3.4 LR-HPV genotypes a HPV 6, 3.4 HPV 11, 1.9 | HIV Positive Any HR-HPVa, 40.0 Type-specific genotypes a HPV 16, 6.7 HPV 18, 3.0 HIV Negative Any HR-HPVa, 29.7 Type-specific genotypes a HPV 16, 3.0 HPV 18, 2.1 | Cumulative prevalence over 27.5 months a HR-HPV types, 68.2% LR-HPV types, 55.0% HPV 16-related types, 48.6% HPV 18-related types, 28.2% |